Prescription Drug Monitoring Program
In February 2016, the Nebraska Legislature passed LB 471, a bill to improve Nebraska's PDMP, or Prescription Drug Monitoring Program. The program will operate through Nebraska's Health Information Exchange (HIE), otherwise known as the Nebraska Health Information Initiative or NeHII.
LB 471, which will begin January 1, 2017, requires that all controlled substances dispensed in Nebraska be reported to the PDMP.
- Required daily reporting of all
dispensed controlled substances by:
- · all
Nebraska pharmacies and
- · all
mail service pharmacies dispensing to an address in Nebraska,
- Preventing patients from opting out of
the PDMP, and
- Providing access to prescribers and
dispensers at no cost.
Prescribers, dispensers, and dispenser’s designees will need
to register to access and view PDMP data. Providers will need to complete the PDMP User Access Request Form and submit it to NeHII at firstname.lastname@example.org. Please note: if you are a prescriber or dispenser and a NeHII Health Information Exchange
(HIE) participant, NeHII staff will automatically enroll you for access to the
Opioid resources master list
Nebraska Prescription Drug Monitoring Program website
Nebraska Medical Association magazine on the PDMP
PDMP implementation guide (updated January 19, 2017)
If you have questions regarding the PDMP registration
process, contact Kevin Borcher, PDMP Director, NeHII, at email@example.com or firstname.lastname@example.org.
If you have general questions pertaining to the PDMP or
opioid misuse prevention efforts, contact Amy Reynoldson, Prescription Drug
Overdose Prevention Coordinator, at email@example.com or (402) 471-0835.